Ricci Flow Nutrition Podcast

John Mitrofanis: Biophotons, Internal Melanins & Photobiomodulation

Apr 11, 2024

John Mitrofanis, world-renowned researcher, discusses biophotons and photobiomodulation for Parkinson's and Alzheimer's. Topics include biophoton release, melanin in cellular communication, water and light's role, methylene blue for Parkinson's, amyloid in Alzheimer's, and alternative perspectives in Alzheimer's research.

51:15

Creator website

Episode guests

John Mitrofanis

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Photobiomodulation offers effective, drug-free treatments for neurodegenerative diseases like Parkinson's and Alzheimer's.

Red and infrared light play vital roles in cell communication and may influence treatments such as red light therapy for Parkinson's disease.

Melanin in the brain could potentially interact with biophotons, aiding in cellular communication and overall brain function.

Deep dives

Photobiomodulation and Neurodegenerative Disease Research

John Mitrophannus, a renowned researcher, focuses on photobiomodulation's impact on neurodegenerative diseases like Parkinson's and Alzheimer's. His work at the Biomedical Research Centre involves exploring drug-free treatments such as exercise and photobiomodulation to prevent and delay disease progression. By studying biophoton release, John aims to understand how neurons and cells emit light, indicating their health status.

Introduction

3min

Exploring the Role of Biophotons and Melanin in Cellular Communication

21min

Unraveling the Mysteries of Biophoton Emissions

6min

The Role of Water and Light in Cellular Functions

9min

Exploring Methylene Blue for Parkinson's and Unifying Similarities with Alzheimer's

3min

Redefining Amyloid in Alzheimer's Disease

5min

Exploring Alternative Perspectives in Alzheimer's Research and Bio-Fotons Impact on Neurodegeneration

3min

John Mitrofanis, PhD, is a world leading researcher on the impact of photobiomodulation and neurodegenerative disease. His work has been centred around seeking effective drug-free treatments and preventative measures for Parkinson’s and Alzheimer’s disease. A former professor of anatomy at the University of Sydney, John is now based in France, where he works at the biomedical research centre, Clinatec in Grenoble France. John is beginning exciting work on biophoton release, examining how photobiomodulation might alter the release of these photons from neurones and other cell types. In his book, Run in the Light, John outlines the most current understanding of the pathologies involved in Parkinson's disease, and how both exercise and photobiomodulation can be used as inexpensive, simple and essentially no-risk modalities to both prevent and delay the progression of the disease. John is extremely humble and open-minded; excellent qualities to explore deep scientific questions.

Listen to our previous conversation

John's Work

- Run In The Light Book

- Why and how does light therapy offer neuroprotection in Parkinson's disease?

- Does photobiomodulation require glucose to work effectively?

My Work